What is LDOS's health score?

Leidos Holdings, Inc. (LDOS) has a TradeApes health score of 65 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LDOS's estimated fair value?

Based on our 5-year discounted cash flow model, Leidos Holdings, Inc.'s estimated fair value is $76.23 per share, representing a -38.8% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LDOS undervalued or overvalued?

Our model currently rates LDOS as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LDOS... Refresh in a moment for the full analysis.

Leidos Holdings, Inc. (LDOS)

Technology Overvalued low healthy

$124.57

Updated: 2026-06-05

TradeApes Score

Financial Strength

80 Strong

Operating Trend

55 Mixed

Relative Value

65 Healthy

Capital Allocation

55 Mixed

Risk

70 Healthy

Est. Fair Value $76.23

DCF Upside -38.8%

Sector Rank #755 of 7597

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Altman Z-Score in grey zone — uncertain financial stability

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.